Chemo Fog : Cancer Chemotherapy-Related Cognitive Impairment /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
New York, NY :
Springer New York : Imprint: Springer,
2010.
|
| Edición: | 1st ed. 2010. |
| Colección: | Advances in Experimental Medicine and Biology,
678 |
| Materias: |
Tabla de Contenidos:
- Short Introduction and History
- Patient’s Perspective
- Oncology Nurse’s Perspective
- Oncology Pharmacist’s Perspective
- The Impact of Chemo Brain on the Patient with a High-Grade Glioma
- Neurocognitive Effects of Childhood Cancer Treatment
- The Economic Burden
- Designing Conceptual Model-Based Research in Chemotherapy-Related Changes in Cognitive Function
- Neuropsychologic Testing for Chemotherapy-Related Cognitive Impairment
- Imaging as a Means of Studying Chemotherapy-Related Cognitive Impairment
- Chemotherapy Associated Central Nervous System Damage
- Is Systemic Anti-Cancer Therapy Neurotoxic? Does Chemo Brain Exist? And Should We Rename It?
- Evaluation of Multiple Neurotoxic Outcomes in Cancer Chemotherapy
- Chemotherapy-Related Visual System Toxicity
- The Possible Role of Cytokines in Chemotherapy-Induced Cognitive Deficits
- Pharmacokinetics of Anti-Cancer Drugs Used in Breast Cancer Chemotherapy
- Combination Analysis
- Animal Models
- Chemo Brain (Chemo Fog) as a Potential Side Effect of Doxorubicin Administration: Role of Cytokine-Induced, Oxidative/Nitrosative Stress in Cognitive Dysfunction
- Effects of 5-FU
- Future Directions.